Trellis Rx

trellisrx.com

Trellis Rx helps health systems change the way patients experience specialty medication therapy. We reduce risk for health systems by partnering with them to fund, build and operate a robust specialty pharmacy program under their brand. As an integrated member of the health system’s care team, Trellis Rx provides patients with personalized pharmacy services and high-touch coordination that improve patient outcomes and drives new revenue for the health system.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

BUSINESS INSIGHTS

SS&C PARTNERS WITH XCENTUATE TO SUPPORT CUSTOMER DIGITAL TRANSFORMATION JOURNEYS

SS&C | June 23, 2022

news image

SS&C Technologies Holdings, Inc. announced a new partnership in the EMEA and APAC regions with Xcentuate, an award-winning international provider of digital productivity and performance solutions to the financial services, agricultural, pharma and public sectors. The partnership follows SS&C's recent acquisition of Blue Prism, the leading Robotic Process Automation provider, further demonstrating its commitment to the intelligent automation solutions market. Xcentuate,...

Read More

PHARMACY MARKET

EAGLE PHARMACEUTICALS AGREED TO ACQUIRE ACACIA PHARMA GROUP PLC

Eagle Pharmaceuticals, Inc. | March 29, 2022

news image

Eagle Pharmaceuticals, Inc. reported that it had achieved an agreement with Acacia Pharma Group plc on the parameters of a plan of arrangement under Part 26 of the United Kingdom's Companies Act 2006. Acacia Pharma's current issued and to be issued, share capital is valued at approximately €94,700,000, or the equivalent of €0.90 per share, under the terms of the proposed transaction. Each Acacia Pharma shareholder would get €0.68 in cash and 0.0049 shares of...

Read More

PHARMA TECH

WINHEALTH AND IMMEDICA ENTER INTO AN AGREEMENT THAT GIVES WINHEALTH THE RIGHTS TO RAVICTI® IN CHINA AND SEVERAL OTHER ASIA-PACIFIC COUNTRIES

WinHealth | January 04, 2021

news image

Hong Kong WinHealth Pharma Group Co., Ltd. furthermore, Immedica Pharma AB, today declared that they have gone into an understanding under which WinHealth has the restrictive business rights to Ravicti® (Glycerol Phenylbutyrate) for Greater China, South Korea, Singapore, Vietnam , Indonesia, Malaysia , the Philippines and Thailand gets. Ravicti® is shown for the treatment of urea cycle issue (UCD) in Europe and North America, and as a feature of the reported association, W...

Read More

BUSINESS INSIGHTS

ERT EXPANDS CLINICAL IMAGING REPORTING CAPABILITIES IN ITS BUSINESS INTELLIGENCE SUITE

ERT | April 16, 2021

news image

ERT, the worldwide pioneer in clinical endpoint data collection, today declared that its demonstrated Business Intelligence suite has extended to incorporate detailing for clinical preliminary imaging, making study data all the more effectively available and noteworthy. The new imaging capabilities give an elevated degree of data that empowers study pioneers to guarantee consummation, and successfully oversee locales, expenses, and profitability. "Imaging studies are complex,...

Read More
news image

BUSINESS INSIGHTS

SS&C PARTNERS WITH XCENTUATE TO SUPPORT CUSTOMER DIGITAL TRANSFORMATION JOURNEYS

SS&C | June 23, 2022

SS&C Technologies Holdings, Inc. announced a new partnership in the EMEA and APAC regions with Xcentuate, an award-winning international provider of digital productivity and performance solutions to the financial services, agricultural, pharma and public sectors. The partnership follows SS&C's recent acquisition of Blue Prism, the leading Robotic Process Automation provider, further demonstrating its commitment to the intelligent automation solutions market. Xcentuate,...

Read More
news image

PHARMACY MARKET

EAGLE PHARMACEUTICALS AGREED TO ACQUIRE ACACIA PHARMA GROUP PLC

Eagle Pharmaceuticals, Inc. | March 29, 2022

Eagle Pharmaceuticals, Inc. reported that it had achieved an agreement with Acacia Pharma Group plc on the parameters of a plan of arrangement under Part 26 of the United Kingdom's Companies Act 2006. Acacia Pharma's current issued and to be issued, share capital is valued at approximately €94,700,000, or the equivalent of €0.90 per share, under the terms of the proposed transaction. Each Acacia Pharma shareholder would get €0.68 in cash and 0.0049 shares of...

Read More
news image

PHARMA TECH

WINHEALTH AND IMMEDICA ENTER INTO AN AGREEMENT THAT GIVES WINHEALTH THE RIGHTS TO RAVICTI® IN CHINA AND SEVERAL OTHER ASIA-PACIFIC COUNTRIES

WinHealth | January 04, 2021

Hong Kong WinHealth Pharma Group Co., Ltd. furthermore, Immedica Pharma AB, today declared that they have gone into an understanding under which WinHealth has the restrictive business rights to Ravicti® (Glycerol Phenylbutyrate) for Greater China, South Korea, Singapore, Vietnam , Indonesia, Malaysia , the Philippines and Thailand gets. Ravicti® is shown for the treatment of urea cycle issue (UCD) in Europe and North America, and as a feature of the reported association, W...

Read More
news image

BUSINESS INSIGHTS

ERT EXPANDS CLINICAL IMAGING REPORTING CAPABILITIES IN ITS BUSINESS INTELLIGENCE SUITE

ERT | April 16, 2021

ERT, the worldwide pioneer in clinical endpoint data collection, today declared that its demonstrated Business Intelligence suite has extended to incorporate detailing for clinical preliminary imaging, making study data all the more effectively available and noteworthy. The new imaging capabilities give an elevated degree of data that empowers study pioneers to guarantee consummation, and successfully oversee locales, expenses, and profitability. "Imaging studies are complex,...

Read More